Multimodal agility-based exercise training (MAT) versus strength and endurance training (SET) to improve multiple sclerosis-related fatigue and fatigability during inpatient rehabilitation: a randomized controlled pilot and feasibility study [ReFEx]

[1] Thompson AJ(2018)Multiple sclerosis Lancet 391 1622-36

[2] Baranzini SE(2020)Fatigue und fatigability bei Multipler Sklerose – Leistungsbeurteilung Die Rehabilit 59 327-9

[3] Geurts J(2019)The effect of self-assessed fatigue and subjective cognitive impairment on work capacity: the case of multiple sclerosis Mult Scler 25 740-9

[4] Hemmer B(2020)Are invisible MS symptoms (fatigue, cognitive dysfunction, depression) significant in the professional performance assessment of multiple sclerosis patients two years after the inpatient primary evaluation? Z Neuropsychol 31 11-25

[5] Ciccarelli O(2023)Fatigue and human performance: an updated Framework Sports Med 53 7-31

[6] Dettmers C(2021)Distinguishing between fatigue and fatigability in multiple sclerosis Neurorehabil Neural Repair 35 960-73

[7] Schmidt R(2017)Assessment of fatigue in multiple sclerosis Neurol Int Open 1 E79-E85

[8] Jöbges M(2013)Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy Neurology 80 409-16

[9] Kobelt G(2021)Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial Lancet Neurol 20 38-48

[10] Langdon D(2021)Which exercise and behavioural interventions show most promise for treating fatigue in multiple sclerosis? A network meta-analysis Mult Scler 27 1657-78

[1] Thompson AJ(2018)Multiple sclerosis Lancet 391 1622-36

[2] Baranzini SE(2020)Fatigue und fatigability bei Multipler Sklerose – Leistungsbeurteilung Die Rehabilit 59 327-9

[3] Geurts J(2019)The effect of self-assessed fatigue and subjective cognitive impairment on work capacity: the case of multiple sclerosis Mult Scler 25 740-9

[4] Hemmer B(2020)Are invisible MS symptoms (fatigue, cognitive dysfunction, depression) significant in the professional performance assessment of multiple sclerosis patients two years after the inpatient primary evaluation? Z Neuropsychol 31 11-25

[5] Ciccarelli O(2023)Fatigue and human performance: an updated Framework Sports Med 53 7-31

[6] Dettmers C(2021)Distinguishing between fatigue and fatigability in multiple sclerosis Neurorehabil Neural Repair 35 960-73

[7] Schmidt R(2017)Assessment of fatigue in multiple sclerosis Neurol Int Open 1 E79-E85

[8] Jöbges M(2013)Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy Neurology 80 409-16

[9] Kobelt G(2021)Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial Lancet Neurol 20 38-48

[10] Langdon D(2021)Which exercise and behavioural interventions show most promise for treating fatigue in multiple sclerosis? A network meta-analysis Mult Scler 27 1657-78